Responses to oleic, linoleic and α-linolenic acids in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1381-1392

  Poudyal, Hemant ^a   Kumar, Senthil A ^b   Iyer, Aarjit ^a   Waanders, Jennifer ^a   Ward, Leigh C ^a   Brown, Lindsay ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Flax; Macadamia; Metabolic syndrome; Omega 3; Omega 6; Omega 9; Safflower

Indexed keywords

ACYL COENZYME A DESATURASE 1; BIOLOGICAL MARKER; CHOLESTEROL; FATTY ACID; GLUCOSE; LINOLEIC ACID; LINOLENIC ACID; LINSEED OIL; OLEIC ACID; SAFFLOWER OIL; SATURATED FATTY ACID; STARCH; SUGAR; TRANS FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID; VEGETABLE OIL; CARBOHYDRATE DIET; FAT INTAKE;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BODY COMPOSITION; CARBOHYDRATE DIET; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLE; DIETARY INTAKE; ENZYME ACTIVITY; FATTY ACID DESATURATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART; HEART DILATATION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; LIPID COMPOSITION; LIPID DIET; LIVER; LIVER FUNCTION; LIVER INJURY; LIVER STRUCTURE; LOW FAT DIET; MACADAMIA; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; ADMINISTRATION AND DOSAGE; ANATOMY AND HISTOLOGY; ANIMAL; DRUG EFFECTS; FAT INTAKE; GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; WISTAR RAT;

CARTHAMUS TINCTORIUS; LINUM USITATISSIMUM; MACADAMIA; RATTUS;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; DIETARY CARBOHYDRATES; DIETARY FATS; GLUCOSE TOLERANCE TEST; LINOLEIC ACID; LINOLENIC ACIDS; LIVER; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; OLEIC ACID; RATS; RATS, WISTAR;

EID: 84879304964     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.11.006     Document Type: Article

References (37)

1. Moussavi N., Gavino V., Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity?. Obesity 2008, 16:7-15.
2. Hunter J.E., Zhang J., Kris-Etherton P.M. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 2010, 91:46-63.
3. Ratnayake W.M., Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab 2009, 55:8-43.
4. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354.
5. Asif M. Health effects of omega-3, 6, 9 fatty acids: Perilla frutescens is a good example of plant oils. Orient Pharm Exp Med 2011, 11:51-59.
6. Gillingham L.G., Harris-Janz S., Jones P.J. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011, 46:209-228.
7. Poudyal H., Panchal S.K., Diwan V., Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011, 50:372-387.
8. Ramsden C.E., Hibbeln J.R., Majchrzak S.F., Davis J.M. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr 2010, 104:1586-1600.
9. Ramsden C.E., Hibbeln J.R., Majchrzak-Hong S.F. All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. World Rev Nutr Diet 2011, 102:30-43.
10. Mozaffarian D., Aro A., Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009, 63(Suppl 2):S5-S21.
11. Teegala S.M., Willett W.C., Mozaffarian D. Consumption and health effects of trans fatty acids: a review. J AOAC Int 2009, 92:1250-1257.
12. Poudyal H., Panchal S.K., Ward L.C., Brown L. Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. J Nutr Biochem 2012, 10.1016/j.jnutbio.2012.07.014.
13. Simopoulos A.P. Evolutionary aspects of diet, essential fatty acids and cardiovascular disease. Eur Heart J Suppl 2001, 3:D8-D21.
14. Gillingham L.G., Gustafson J.A., Han S.Y., Jassal D.S., Jones P.J. High-oleic rapeseed (canola) and flaxseed oils modulate serum lipids and inflammatory biomarkers in hypercholesterolaemic subjects. Br J Nutr 2011, 105:417-427.
15. Kris-Etherton P.M. AHA science advisory: monounsaturated fatty acids and risk of cardiovascular disease. J Nutr 1999, 129:2280-2284.
16. Poudyal H., Panchal S.K., Waanders J., Ward L., Brown L. Lipid redistribution by alpha-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem 2012, 23:153-162.
17. Poudyal H., Campbell F., Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 2010, 140:946-953.
18. Panchal S.K., Poudyal H., Iyer A., Nazer R., Alam M.A., Diwan V., et al. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 2011, 57:611-624.
19. Sahn D.J., Allen H.D. Real-time cross-sectional echocardiographic imaging and measurement of the patent ductus arteriosus in infants and children. Circulation 1978, 58:343-354.
20. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
21. Moscatiello S., Di Luzio R., Sasdelli A.S., Marchesini G. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. Expert Opin Pharmacother 2011, 12:2657-2672.
22. Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124:903-915.
23. Visioli F., Bernardini E. Extra virgin olive oil's polyphenols: biological activities. Curr Pharm Des 2011, 17:786-804.
24. Fritsche K.L. Too much linoleic acid promotes inflammation-doesn't it?. Prostaglandins Leukot Essent Fatty Acids 2008, 79:173-175.
25. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009, 77:937-946.
26. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
27. Benatti P., Peluso G., Nicolai R., Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 2004, 23:281-302.
28. Stanley J.C., Elsom R.L., Calder P.C., Griffin B.A., Harris W.S., Jebb S.A., et al. UK Food Standards Agency Workshop Report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. Br J Nutr 2007, 98:1305-1310.
29. Bartsch H., Nair J., Owen R.W. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999, 20:2209-2218.
30. Griffin B.A. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 2008, 19:57-62.
31. Chicco A.G., D'Alessandro M.E., Hein G.J., Oliva M.E., Lombardo Y.B. Dietary chia seed (Salvia hispanica L.) rich in alpha-linolenic acid improves adiposity and normalises hypertriacylglycerolaemia and insulin resistance in dyslipaemic rats. Br J Nutr 2009, 101:41-50.
32. Vuksan V., Whitham D., Sievenpiper J.L., Jenkins A.L., Rogovik A.L., Bazinet R.P., et al. Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007, 30:2804-2810.
33. Brouwer I.A., Katan M.B., Zock P.L. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004, 134:919-922.
34. Poudyal H., Panchal S.K., Ward L.C., Waanders J., Brown L. Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab 2012, 302:E1472-E1482.
35. Micha R., Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009, 5:335-344.
36. Mozaffarian D. Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006, 7:29-32.
37. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.